154 related articles for article (PubMed ID: 32274652)
1. Neuropsychological functioning among patients with different types of cancer : Postchemotherapy cognitive impairment and implications for rehabilitation.
Megari K
Neuropsychiatr; 2021 Jun; 35(2):92-97. PubMed ID: 32274652
[TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.
Cerulla N; Arcusa À; Navarro JB; de la Osa N; Garolera M; Enero C; Chico G; Fernández-Morales L
J Clin Exp Neuropsychol; 2019 Apr; 41(3):290-299. PubMed ID: 30477390
[TBL] [Abstract][Full Text] [Related]
3. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
4. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.
Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR
J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological Effects of Chemotherapy: Systematic Review of Longitudinal Studies on Objective Cognitive Impairment in Breast Cancer Patients.
Kim HJ; Kim JEE; Jung SO; Lee D; Abraham I
Cancer Nurs; 2023 May-Jun 01; 46(3):E159-E168. PubMed ID: 35324504
[TBL] [Abstract][Full Text] [Related]
6. An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors.
Cheung YT; Tan EH; Chan A
Support Care Cancer; 2012 Jul; 20(7):1361-75. PubMed ID: 22476439
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal investigation of cognitive deficits in breast cancer patients and their gray matter correlates: impact of education level.
Perrier J; Viard A; Levy C; Morel N; Allouache D; Noal S; Joly F; Eustache F; Giffard B
Brain Imaging Behav; 2020 Feb; 14(1):226-241. PubMed ID: 30406352
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.
Jim HS; Phillips KM; Chait S; Faul LA; Popa MA; Lee YH; Hussin MG; Jacobsen PB; Small BJ
J Clin Oncol; 2012 Oct; 30(29):3578-87. PubMed ID: 22927526
[TBL] [Abstract][Full Text] [Related]
9. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
10. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study.
Hermelink K; Untch M; Lux MP; Kreienberg R; Beck T; Bauerfeind I; Münzel K
Cancer; 2007 May; 109(9):1905-13. PubMed ID: 17351951
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.
Jansen CE; Miaskowski CA; Dodd MJ; Dowling GA
Oncol Nurs Forum; 2007 Sep; 34(5):997-1005. PubMed ID: 17878128
[TBL] [Abstract][Full Text] [Related]
12. [Cognitive deficits with chemotherapy in women with breast cancer: a bibliographic revisión].
Arce B; Grañana N
Rev Fac Cien Med Univ Nac Cordoba; 2023 Jun; 80(2):126-133. PubMed ID: 37402295
[TBL] [Abstract][Full Text] [Related]
13. Physical Activity Patterns and Relationships With Cognitive Function in Patients With Breast Cancer Before, During, and After Chemotherapy in a Prospective, Nationwide Study.
Salerno EA; Culakova E; Kleckner AS; Heckler CE; Lin PJ; Matthews CE; Conlin A; Weiselberg L; Mitchell J; Mustian KM; Janelsins MC
J Clin Oncol; 2021 Oct; 39(29):3283-3292. PubMed ID: 34406822
[TBL] [Abstract][Full Text] [Related]
14. Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.
Kesler SR; Blayney DW
JAMA Oncol; 2016 Feb; 2(2):185-92. PubMed ID: 26633037
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study.
Fischer B
Neurocase; 2019; 25(3-4):138-144. PubMed ID: 31237172
[TBL] [Abstract][Full Text] [Related]
16. Association of chemotherapy and subjective cognitive impairment in breast cancer patients: Meta-analysis of longitudinal prospective cohort studies.
Kim HJ; Jung SO; Kim E; Abraham I
Eur J Oncol Nurs; 2022 Apr; 57():102099. PubMed ID: 35255262
[TBL] [Abstract][Full Text] [Related]
17. [Chemobrain - cognitive disorders after chemotherapy].
Kupryjaniuk A; Sobstyl M
Pol Merkur Lekarski; 2022 Dec; 50(300):398-400. PubMed ID: 36645690
[TBL] [Abstract][Full Text] [Related]
18. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study.
Cheung YT; Ng T; Shwe M; Ho HK; Foo KM; Cham MT; Lee JA; Fan G; Tan YP; Yong WS; Madhukumar P; Loo SK; Ang SF; Wong M; Chay WY; Ooi WS; Dent RA; Yap YS; Ng R; Chan A
Ann Oncol; 2015 Jul; 26(7):1446-51. PubMed ID: 25922060
[TBL] [Abstract][Full Text] [Related]
19. Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy.
Dhillon HM; Tannock IF; Pond GR; Renton C; Rourke SB; Vardy JL
J Cancer Surviv; 2018 Apr; 12(2):178-185. PubMed ID: 29080061
[TBL] [Abstract][Full Text] [Related]
20. The impact of chemotherapy on cognitive performance post-surgery in patients with colorectal cancer: A prospective cohort study.
Dwek MR; Newman SP; Brini S; Holder P; Machesney M; Propper D; Rixon LR; Hirani SP; Hurt CS
Psychooncology; 2023 Jul; 32(7):1057-1066. PubMed ID: 37208950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
